Global Invasive Ductal Carcinoma Treatment Market Size & Outlook
Global invasive ductal carcinoma treatment market, 2018-2030 (US$M)
Related Markets
Global invasive ductal carcinoma treatment market highlights
- The global invasive ductal carcinoma treatment market generated a revenue of USD 9,323.1 million in 2024 and is expected to reach USD 15,210.4 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.5% by 2030.
- In terms of segment, targeted therapy accounted for a revenue of USD 6,627.2 million in 2024.
- Immunotherapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 9,323.1 million |
| Market revenue in 2030 | USD 15,210.4 million |
| Growth rate | 8.5% (CAGR from 2025 to 2030) |
| Largest segment | Targeted therapy |
| Fastest growing segment | Immunotherapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global invasive ductal carcinoma treatment market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 314.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Invasive Ductal Carcinoma Treatment Market Scope
Invasive Ductal Carcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Celldex Therapeutics Inc | View profile | 160 | 53 Frontage Road, Suite 220, Perryville III Building, Hampton, NJ, United States, 08827 | https://www.celldex.com |
| Janssen Pharmaceuticals | View profile | 1-10 | Titusville, New Jersey, United States, North America | https://www.xarelto-us.com |
| Macrogenics Inc | View profile | 339 | 9704 Medical Center Drive, Rockville, MD, United States, 20850 | https://www.macrogenics.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global invasive ductal carcinoma treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to invasive ductal carcinoma treatment market will help companies and investors design strategic landscapes.
Targeted therapy was the largest segment with a revenue share of 71.08% in 2024. Horizon Databook has segmented the Global invasive ductal carcinoma treatment market based on targeted therapy, hormonal therapy, chemotherapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Invasive Ductal Carcinoma Treatment Therapy Outlook (Revenue, USD Million, 2018-2030)
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Global Invasive Ductal Carcinoma Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Hormone Receptor
- HER2+
- Global Invasive Ductal Carcinoma Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Retail pharmacies
- Hospital pharmacies
- Others
Reasons to subscribe to Global invasive ductal carcinoma treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global invasive ductal carcinoma treatment market databook
-
Our clientele includes a mix of invasive ductal carcinoma treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global invasive ductal carcinoma treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global invasive ductal carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global invasive ductal carcinoma treatment market size, by regions, 2018-2030 (US$M)
Top 10 countries: Invasive ductal carcinoma treatment market size, 2024 (US$M)
Global invasive ductal carcinoma treatment market share, by therapy, 2024 & 2030 (%, US$M)
Invasive ductal carcinoma treatment market: Opportunity assessment by country
Global invasive ductal carcinoma treatment market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
